
Carriage of Cytochrome 2C19 Polymorphism Is Associated With Risk of High Post-Treatment Platelet Reactivity on High Maintenance-Dose Clopidogrel of 150 mg/day : Results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidogrel A
Keywords: آدنوزین دی فسفات; platelet; high post-treatment platelet reactivity; CYP2C19 polymorphism; high maintenance-dose clopidogrelACS, acute coronary syndrome; ADP, adenosine diphosphate; BMI, body mass index; CKD, chronic kidney disease; CYP, the hepatic cytochrome P450; DNA, d